Altimmune ALT Earnings Call Transcripts

NASDAQ ALT
$1.93 -0.01 (-0.52%)
At close: Nov 11, 2026 · 4:00 PM EST
9 earnings calls on file for Altimmune, from Q4 2020 to Q1 2026. Each transcript opens in a new tab.
Latest earnings call

Altimmune Q1 2026 Earnings Call

May 13, 2026 7,624 words · 33 min read
  • Jerome DursoPresident and Chief Executive Officer
  • Christophe Arbet-EngelsChief Medical Officer
  • Linda RichardsonChief Commercial Officer
  • Gregory WeaverChief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Altimmune Earnings Call Transcripts

Calls9
LatestMay 13, 2026
SinceQ4 2020

Fiscal 2026

Fiscal 2025

Fiscal 2022

Fiscal 2021

Fiscal 2020

All 9 Altimmune transcripts Register to get access to Altimmune’s earnings call transcripts.